【24h】

Performance of Different DFT/ECP Combinations in the Study of Platinum Anticancer Drugs

机译:DFT / ECP组合在铂类抗癌药物研究中的性能

获取原文

摘要

In the present study the performance of several combinations of ab initio molecular orbital methods was evaluated, aiming at a thorough conformational analysis of the well-known anticancer agent cisplatin (cis-diamminedichloroplatinum (II), cDDP). Different DFT/ECP approaches were tested, coupling the relativistic ECP's CEP-4G/CEP-31G and LANL2MB/LANL2DZ to the DFT approximations B3LYP and mPW1PW. From an energetic point of view, the results obtained were compared with the ones yielded by the AE basis sets 6-31G~* and 6-311G~(**) (at both the HF and MP2 levels). The type of ECP considered and inclusion of an f-polarisation function at the Pt valence shell were found to be determinant for an accurate reproduction of the AE results for this Pt(II) chelate, while the effect of the DFT protocol used proved to be of little significance.
机译:在本研究中,对从头算分子轨道方法的几种组合的性能进行了评估,目的是对著名的抗癌药顺铂(顺二氨二氯铂(II),cDDP)进行彻底的构象分析。测试了不同的DFT / ECP方法,将相对论ECP的CEP-4G / CEP-31G和LANL2MB / LANL2DZ耦合到DFT近似值B3LYP和mPW1PW。从能量的角度来看,将获得的结果与AE基础集6-31G〜*和6-311G〜(**)(在HF和MP2水平下)得出的结果进行比较。已发现考虑的ECP类型和在Pt价壳上包含f极化功能是该Pt(II)螯合物的AE结果准确复制的决定因素,而使用的DFT协议的效果被证明是没什么意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号